Literature DB >> 11318937

Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome.

M Buzza1, D Wilson, J Savige.   

Abstract

BACKGROUND: Inherited hematuria is common and is usually attributed to thin basement membrane disease (TBMD). The aim of this study was to determine how often hematuria in families with TBMD segregated with haplotypes at the chromosomal loci for autosomal recessive and X-linked Alport syndrome (COL4A3/COL4A4 and COL4A5, respectively).
METHODS: The families of 22 individuals with TBMD on renal biopsy and with urinary glomerular red blood cell (RBC) counts of more than 50,000/mL were studied using phase-contrast microscopy of the urine and DNA microsatellite markers. Eighteen families had at least two members with hematuria.
RESULTS: Hematuria segregated with or was consistent with segregation at the COL4A3/COL4A4 locus in eight (36%) families (P < 0.05 in 5 of these) and at the COL4A5 locus in four (18%) families (P < 0.05 in 2). The lack of segregation in the other 10 (45%) families may have occurred because of incomplete penetrance of the hematuria, de novo mutations, coincidental hematuria in other family members, or the presence of a novel gene locus. In four different families, three of which had hematuria that segregated with the COL4A3/COL4A4 locus, four family members with the hematuria haplotype had spouses with coincidental hematuria (4 of 29, 14%). However, none of their four offspring who had also inherited the hematuria haplotype had the clinical features of autosomal recessive Alport syndrome.
CONCLUSIONS: Hematuria in families with TBMD commonly segregates with the COL4A3/COL4A4 locus and thus results from mutations in the same genes as autosomal recessive Alport syndrome. Sometimes TBMD may be confused with the carrier state for X-linked Alport syndrome. However, nearly half of the families in this study had hematuria that did not segregate with the loci for either autosomal recessive or X-linked Alport syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11318937     DOI: 10.1046/j.1523-1755.2001.0590051670.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases.

Authors:  Kesha Rana; Stephen Tonna; Yan Yan Wang; Lydia Sin; Tina Lin; Elizabeth Shaw; Ishanee Mookerjee; Judy Savige
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

Review 2.  Living donor kidney transplantation in patients with hereditary nephropathies.

Authors:  Patrick Niaudet
Journal:  Nat Rev Nephrol       Date:  2010-09-28       Impact factor: 28.314

Review 3.  Ocular features in Alport syndrome: pathogenesis and clinical significance.

Authors:  Judy Savige; Shivanand Sheth; Anita Leys; Anjali Nicholson; Heather G Mack; Deb Colville
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-03       Impact factor: 8.237

4.  Do mutations in COL4A1 or COL4A2 cause thin basement membrane nephropathy (TBMN)?

Authors:  Ke Wei Zhang; Stephen Tonna; Yan Yan Wang; Kesha Rana; Smitha Padavarat; Judy Savige
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

5.  Value of urinary excretion of microalbumin in predicting glomerular lesions in children with isolated microscopic hematuria.

Authors:  Farahnak K Assadi
Journal:  Pediatr Nephrol       Date:  2005-06-08       Impact factor: 3.714

6.  Persistent familial hematuria in children and the locus for thin basement membrane nephropathy.

Authors:  Kesha Rana; Yan Yan Wang; Harley Powell; Colin Jones; David McCredie; Mark Buzza; Madhara Udawela; Judy Savige
Journal:  Pediatr Nephrol       Date:  2005-10-19       Impact factor: 3.714

7.  Prevalence Estimates of Predicted Pathogenic COL4A3-COL4A5 Variants in a Population Sequencing Database and Their Implications for Alport Syndrome.

Authors:  Joel Gibson; Rachel Fieldhouse; Melanie M Y Chan; Omid Sadeghi-Alavijeh; Leslie Burnett; Valerio Izzi; Anton V Persikov; Daniel P Gale; Helen Storey; Judy Savige
Journal:  J Am Soc Nephrol       Date:  2021-06-18       Impact factor: 14.978

8.  The R229Q mutation in NPHS2 may predispose to proteinuria in thin-basement-membrane nephropathy.

Authors:  Stephen Tonna; Yan Yan Wang; Diane Wilson; Lin Rigby; Tania Tabone; Richard Cotton; Judy Savige
Journal:  Pediatr Nephrol       Date:  2008-08-26       Impact factor: 3.714

9.  Frequency of COL4A3/COL4A4 mutations amongst families segregating glomerular microscopic hematuria and evidence for activation of the unfolded protein response. Focal and segmental glomerulosclerosis is a frequent development during ageing.

Authors:  Louiza Papazachariou; Panayiota Demosthenous; Myrtani Pieri; Gregory Papagregoriou; Isavella Savva; Christoforos Stavrou; Michael Zavros; Yiannis Athanasiou; Kyriakos Ioannou; Charalambos Patsias; Alexia Panagides; Costas Potamitis; Kyproula Demetriou; Marios Prikis; Michael Hadjigavriel; Maria Kkolou; Panayiota Loukaidou; Androulla Pastelli; Aristos Michael; Akis Lazarou; Maria Arsali; Loukas Damianou; Ioanna Goutziamani; Andreas Soloukides; Lakis Yioukas; Avraam Elia; Ioanna Zouvani; Polycarpos Polycarpou; Alkis Pierides; Konstantinos Voskarides; Constantinos Deltas
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

Review 10.  How benign is hematuria? Using genetics to predict prognosis.

Authors:  Daniel P Gale
Journal:  Pediatr Nephrol       Date:  2013-01-17       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.